This review prioritised the extension of MediShield Life coverage to medical treatments that:

a.    Are high-cost and low-incidence, in line with focus of MediShield Life coverage on catastrophic medical episodes which can benefit from risk pooling;

b.    Are clinically and cost-effective;

c.     Have significant affordability gaps; and/or

d.    Can support shifting of care from hospital to outpatient, community or home.

The approach balances between enhancing affordability for patients while keeping premiums affordable for all.